(WXYZ) – The CDC is investigating after a woman from Michigan died after receiving Johnson & Johnson’s COVID-19 vaccine.
Anne Vangeest’s family, 35, from Ionia County, was vaccinated on April 8, just five days before the CDC and FDA paused on a single vaccination due to blood clot concerns. She died on April 19, her family said.
The pause was lifted on April 23 after scientific advisors decided that the benefits of the J&J vaccine outweigh the risks of developing blood clots. At the time, it was discovered that 15 women had blood clots.Of the nearly 8 million people who received this injection, roughly. 01%
On April 23, three women died and seven others remained in hospital.
Vangeest’s family released a statement saying she “As a loving mother, wife, sister and daughter and an active member of the animal rescue community, Annie will be remembered as a fierce advocate, multi-worker and caring coworker. Volunteer friends and family “
In an email to the VanGeest family, the U.S. Centers for Disease Control and Prevention (CDC) confirmed her death was reported through the Vaccine Adverse Event Reporting System (VAERS) by the VAERS healthcare provider as a safety system. Of vaccines administered by the CDC and the FDA
“VAERS accepts reports of possible side effects. (Also called “adverse events”) after vaccination. The system was not designed to determine whether an adverse event reported was caused by a vaccine. “When the VAERS receives a report of serious illness or death following a vaccination, VAERS staff will contact the hospital at http://www.aer.org. Patients were treated to obtain relevant medical records to better understand the adverse events. ”
Additional Coronavirus Information and Resources:
View files Global coronavirus tracker With data from Johns Hopkins University.
See all our coverage Coronavirus Continuity Coverage Page
Visit Detroit revival A place where we are working to help people who are financially affected by the coronavirus. We have all the information to help you get through this crisis and how to approach it.